Header Logo

Sheila Dowd

Concepts (78)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Phobia, Social
4
2023
13
0.750
Why?
Cycloserine
5
2023
26
0.700
Why?
Implosive Therapy
4
2023
19
0.600
Why?
Transcranial Magnetic Stimulation
6
2015
17
0.410
Why?
Depressive Disorder, Major
4
2015
102
0.340
Why?
Antimetabolites
3
2019
13
0.320
Why?
Clonazepam
3
2003
26
0.310
Why?
Treatment Outcome
10
2023
3615
0.210
Why?
Flunitrazepam
1
2002
1
0.200
Why?
Substance Abuse Treatment Centers
1
2002
2
0.200
Why?
GABA Modulators
1
2002
4
0.200
Why?
Rape
1
2002
6
0.200
Why?
Anti-Anxiety Agents
1
2002
39
0.200
Why?
Antibiotics, Antitubercular
1
2020
2
0.180
Why?
Antidepressive Agents
2
2015
98
0.140
Why?
Extinction, Psychological
3
2023
13
0.140
Why?
Adult
12
2021
8107
0.140
Why?
Electroconvulsive Therapy
3
2007
16
0.140
Why?
Double-Blind Method
4
2020
433
0.130
Why?
Depressive Disorder, Treatment-Resistant
1
2015
10
0.130
Why?
Panic Disorder
1
2016
133
0.120
Why?
Humans
16
2023
28436
0.110
Why?
Depressive Disorder
2
2007
186
0.110
Why?
Combined Modality Therapy
3
2023
307
0.110
Why?
Phobic Disorders
1
2013
66
0.110
Why?
Behavior Therapy
1
2013
91
0.100
Why?
Fear
2
2023
46
0.100
Why?
Anxiety Disorders
2
2023
172
0.100
Why?
Sleep Wake Disorders
1
2013
130
0.100
Why?
Female
11
2020
15730
0.090
Why?
Male
10
2020
15291
0.090
Why?
Middle Aged
9
2016
9269
0.080
Why?
Psychiatric Status Rating Scales
4
2013
326
0.070
Why?
Placebos
2
2020
71
0.070
Why?
Anticonvulsants
2
2007
57
0.070
Why?
Attention
2
2003
131
0.060
Why?
Substance Abuse Detection
1
2003
5
0.050
Why?
Electric Stimulation
1
2003
53
0.050
Why?
Severity of Illness Index
2
2020
988
0.050
Why?
Forensic Medicine
1
2002
1
0.050
Why?
Hair
1
2002
3
0.050
Why?
Anxiety
1
2023
161
0.050
Why?
Recurrence
2
2015
322
0.050
Why?
Pilot Projects
2
2015
440
0.050
Why?
Memory
1
2002
302
0.040
Why?
Cognition Disorders
2
2007
1003
0.040
Why?
Drug Administration Schedule
1
2020
166
0.040
Why?
Galvanic Skin Response
1
2019
7
0.040
Why?
Photic Stimulation
1
2019
27
0.040
Why?
Placebo Effect
1
2019
19
0.040
Why?
Young Adult
2
2016
2069
0.040
Why?
Mental Recall
1
2019
63
0.040
Why?
Case-Control Studies
1
2020
594
0.040
Why?
Prospective Studies
2
2015
1809
0.040
Why?
Time Factors
2
2015
1491
0.030
Why?
Retreatment
1
2015
8
0.030
Why?
Watchful Waiting
1
2015
12
0.030
Why?
Drug Resistance
1
2015
47
0.030
Why?
Feasibility Studies
1
2015
232
0.030
Why?
Gas Chromatography-Mass Spectrometry
2
2003
13
0.030
Why?
Predictive Value of Tests
1
2013
492
0.020
Why?
Comorbidity
1
2013
500
0.020
Why?
Adolescent
2
2011
2307
0.020
Why?
Kaplan-Meier Estimate
1
2010
179
0.020
Why?
Aged
2
2015
9277
0.020
Why?
Clinical Trials as Topic
1
2007
239
0.020
Why?
Research Design
1
2007
207
0.020
Why?
Follow-Up Studies
1
2010
1859
0.020
Why?
Age Factors
1
2007
781
0.010
Why?
Reference Standards
1
2003
25
0.010
Why?
Calibration
1
2003
21
0.010
Why?
Reaction Time
1
2003
106
0.010
Why?
Memory, Short-Term
1
2003
100
0.010
Why?
Electromagnetic Fields
1
2002
8
0.010
Why?
Psychomotor Performance
1
2003
213
0.010
Why?
Sensitivity and Specificity
1
2003
517
0.010
Why?
Motor Activity
1
2003
329
0.010
Why?
Neuropsychological Tests
1
2003
1226
0.010
Why?
Dowd's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_